BCAB
Bioatla Inc
NASDAQ: BCAB · HEALTHCARE · BIOTECHNOLOGY
$4.21
+4.21% today
Updated 2026-04-30
Market cap
$8.07M
P/E ratio
—
P/S ratio
4.04x
EPS (TTM)
$-50.50
Dividend yield
—
52W range
$4 – $72
Volume
1.0M
Bioatla Inc (BCAB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-462.80%
ROE
-814.00%
ROA
-110.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $10.63M | $-28.98M | -147.53% | -265.68% | -272.69% |
| 2019 | $5.20M | $-29.79M | -398.44% | -543.62% | -572.96% |
| 2020 | $429000.00 | $-35.85M | -4,546.39% | -7,016.08% | -8,357.34% |
| 2021 | $250000.00 | $-95.40M | 100.00% | -38,576.00% | -38,160.80% |
| 2022 | $0.00 | $-105.28M | — | — | — |
| 2023 | $0.00 | $-123.46M | — | — | — |
| 2024 | $11.00M | $-69.78M | 91.59% | -672.21% | -634.33% |
| 2025 | $2.00M | $-59.61M | 100.00% | -2,965.25% | -2,980.35% |